Isparocto 3000 for intravenous injection contains Turoctocog Alpha Pegol, a recombinant Factor VIII therapy for hemophilia A. Developed by Novo Nordisk Pharma, this injectable (YJ code: 6343454D5020) is available as a 3,000 IU bottle with dissolving solution.
Isparocto 3000 for intravenous injection
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).